Dyno Therapeutics

Associate Director, Medical Writing

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Biotechnology ResearchIndustries

Requirements

Candidates must possess a minimum of a Bachelor's degree in Life Sciences or a related discipline, with an advanced degree being preferred. A solid understanding of biochemistry and molecular biology principles is required, along with a minimum of 5 years of experience writing clinical and regulatory documents for a pharmaceutical or biotechnology company. Proficiency in writing, editing, and reviewing protocols, clinical study reports, investigator brochures, CTD modules, and other clinical regulatory documents per guidelines is essential. Knowledge of FDA/international regulations, ICH guidelines, and applicable US/international regulatory processes is necessary. Candidates should be proficient with Microsoft Office, Adobe Acrobat, and shared document systems like SharePoint and Veeva. The ability to work independently, prioritize tasks, problem-solve, complete high-quality documents under aggressive timelines, and a commitment to accuracy and detail are also required.

Responsibilities

The Associate Director, Medical Writing is responsible for the timely preparation of high-quality, compliant clinical and regulatory documents for one or more clinical programs. This includes writing, editing, and collaborating on protocols, investigator brochures, clinical study reports, CTDs, and briefing books. The role involves reviewing and ensuring the quality of documents prepared by others, overseeing document review comment resolution meetings, and contributing to project management and cross-functional working groups to facilitate document development. Additionally, the position supports the development of best practices for authoring and reviewing, focusing on continuous process improvement.

Skills

Medical Writing
Clinical Protocols
Investigator Brochures
Clinical Study Reports
CTDs
Briefing Books
Regulatory Documents
ICH/GCP/Regulatory Guidelines
Communication Skills
Editing
Collaboration

Dyno Therapeutics

Develops AI-optimized gene therapy vectors

About Dyno Therapeutics

Dyno Therapeutics focuses on advancing gene therapy by utilizing Artificial Intelligence to create Adeno-associated virus (AAV) vectors. These vectors are essential tools for delivering genetic material into cells, which is crucial for effective gene therapy. The company's AI technology enables the design and optimization of these vectors, potentially enhancing the success of gene therapies. Dyno collaborates with major pharmaceutical and biotech companies, such as Astellas, Roche, Sarepta, and Novartis, to develop therapies for various diseases affecting the skeletal and cardiac muscles, central nervous system, liver, and eyes. Unlike many competitors, Dyno's unique approach leverages AI to improve the performance of AAV vectors, setting it apart in the biotech field. The company's goal is to improve gene therapy outcomes through its advanced vector technology, ultimately benefiting patients with serious health conditions.

Watertown, MassachusettsHeadquarters
2018Year Founded
$106MTotal Funding
SERIES_ACompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Remote Work Options

Risks

Gene therapy investment slowdown may impact Dyno's growth and innovation.
Manufacturing bottlenecks could hinder scaling of Dyno's operations.
Increased competition from companies like Form Bio challenges Dyno's market position.

Differentiation

Dyno uses AI to design optimized AAV vectors for gene therapy.
Their AI-driven CapsidMap platform enhances AAV vector development for muscle gene therapies.
Partnerships with major pharma companies like Astellas and Roche boost Dyno's market presence.

Upsides

AI-driven capsid design improves delivery efficiency and reduces manufacturing costs.
Collaboration with NVIDIA enhances biological sequence design for gene therapies.
Generative AI increases efficiency of eye and brain-targeted capsid delivery significantly.

Land your dream remote job 3x faster with AI